February 6, 2025
CLASH enables large-scale parallel knock-in for cell engineering

Nature Biotechnology, Published online: 26 January 2023; doi:10.1038/s41587-023-01664-4CLASH is a CRISPR-based platform that enables the parallel knock-in via homology-directed repair of a large pool of transgene variants encoded in adeno-associated virus vectors. CLASH can be applied to the systematic and unbiased selection of favorable features in T cells and…
Read More

About The Author

Leave a Reply

Your email address will not be published. Required fields are marked *